Background: Previous meta-analyses have only found small correlations (r = .10 to r = .19) between therapeutic alliance and clinical outcomes in samples of adolescents receiving psychological therapy. Although study-level variables have been found to moderate this, little is known about the impact of therapist variability. The present meta-analysis aimed to address this gap by using patient-therapist ratio as a moderator variable. Methods: Contrary to previous reviews of adolescent alliance, individual effect sizes were extracted using a preregistered conceptual hierarchy. Controlling for treatment-level confounds, a random effects meta-analysis assessed the moderating effect of patient-therapist ratio on the alliance-outcome relationship in predefined single-predictor and multipredictor meta-regressions. Results: The alliance-outcome relationship was found to be larger than previously thought (k = 28, N = 2,911, r = .29, 95% Confidence Interval 0.21, 0.37; p < .0001, I 2 = 80%). When study samples exceeding the adolescent 12-19 age range were removed, the correlation rose (k = 15, N = 1,797, r = .34, 95% Confidence Interval 0.23, 0.45; p < .0001, I 2 = 83%). In contrast to research with adults, patient-therapist ratio did not moderate this relationship in either single-predictor (p = .26) or multi-predictor (p = .22) models. Conclusions: The allianceoutcome relationship for adolescents was larger than previously thought, and comparable to estimates in adult samples. The failure of patient-therapist ratio to moderate its strength, however, challenges the hypothesis that variability in therapist characteristics is an important determinant of the alliance-outcome effect in this age group.
Introduction

Alliance conceptualisation & rater perspective
Alliance is an umbrella term used to denote relational aspects of psychological treatment. It was first spoken of within the context of psychodynamic therapy and had close conceptual links to constructs such as positive transference (Freud, 1958) . Due to increased scientific interest, our understanding of the alliance concept has evolved, giving rise to a range of definitions and associated labels. Drawing on models first proposed by Luborsky (1976) and Bordin (1979) , alliance is now commonly described as a multidimensional construct. As such, it incorporates elements relating to reciprocal affect, patient-therapist agreement, and collaboration.
While differences in treatment contexts may be substantial across young patients, alliance is undoubtedly influenced by how adolescents experience service involvement. This is also evident in welldocumented links between adolescent alliance ratings and factors such as retention, engagement and service satisfaction (Florsheim, Shotorbani, GuestWarnick, Barratt, & Hwang, 2000; Hawley & Weisz, 2005; Shirk & Saiz, 1992) . Examining adolescent perceptions of alliance can therefore provide valuable insights into patient experiences of participating in psychological treatment and inform routine practice in mental health services. With the importance of this in mind, the present metaanalysis specifically focuses on alliance as assessed through adolescent self-report.
Alliance-outcome relationship
The link between alliance and treatment outcome has been quantified over decades of empirical research and yields consistently replicable positive correlations. With effect sizes ranging from r = .22 to r = .28, meta-analytic estimates of the alliance-outcome relationship appear to be fairly robust and nearly reach moderate magnitudes for adult mental health patients (Horvath, Del Re, Fl€ uckiger, & Symonds, 2011; Martin, Garske, & Davis, 2000) . At present, differences in adult alliance can therefore be linked to approximately 5%-8% of variability in treatment outcomes. While this might only represent a fraction among other variables, alliance has become a commonly referenced predictor of treatment success and is presumed to contribute to symptomatic improvements in adult patients (e.g. Falkenstr€ om, Granstr€ om, & Holmqvist, 2013) . As recent reviews indicate, the alliance-outcome relationship in adolescent mental health patients is somewhat weaker than its adult counterpart. With current effect sizes ranging from r = .10 to r = .19, meta-analytic estimates for this age group are clearly small in size (McLeod, 2011; Shirk, Karver, & Brown, 2011) . Differences in adolescent alliance can thus only be linked to approximately 1%-4% of variability in treatment outcomes, indicating little prognostic value.
Moderator variables in adolescent patients
While effect size differences between adults and adolescents are now well documented, the focus has gradually shifted towards examining effect size variation within clinical populations. In recent metaanalyses, numerous variables have been shown to moderate the alliance-outcome relationship in adolescent patient samples. Problem type, referral source, and timing of alliance assessment, for instance, are among a range of identified moderators and can be linked to some of the variance observed in alliance-outcome correlations (McLeod, 2011; Shirk & Karver, 2003) . On a theoretical level, these findings indicate that estimates of the allianceoutcome relationship are not uniform across adolescent patients. As a number of primary studies confirm, alliance may not always be linked to treatment outcome to the same degree, with some correlations not reaching statistical significance (Kendall, 1994; Kendall et al., 1997) . This suggests that even positive alliance may not consistently predict treatment success in the presence of certain variables.
Role of therapist variability
While alliance-outcome moderators have been linked to a number of factors within the therapeutic process, comparatively little is known about the impact therapist characteristics have on the alliance-outcome relationship. As highlighted in relevant systematic reviews, therapist variables have been widely neglected in empirical research and received unexpectedly little attention in clinical discourse (e.g. Ackerman & Hilsenroth, 2003) . With the exception of individual studies in the adult field, the impact of therapist variability within psychological treatment is still underexplored in the adolescent population (e.g. Heinonen et al., 2014; Jung, Wiesjahn, Rief, & Lincoln, 2015) . Considering the pivotal role therapists play in treatment delivery and patient discharge, this knowledge gap is more than surprising. Previous meta-analyses addressed this issue to varying degrees, but largely failed to incorporate therapist variables altogether (e.g. Shirk & Karver, 2003; Shirk et al., 2011) . As an appraisal of eligible literature suggests, this relates to a lack of relevant data collection across primary studies and can often be linked to inadequate reporting of therapist-related information (Karver, Handelsman, Fields, & Bickman, 2005) .
Rationale
Considering the paucity of available therapist data across adolescent literature, informative conclusions about the role of therapist variability could not be drawn so far. Accordingly, it remains unclear to what extent differences between therapists actually affect the alliance-outcome relationship. Using a comparatively novel methodological approach, the present meta-analysis aims to address this gap. Following a recent review of adult literature, the impact of therapist variability on the alliance-outcome relationship was examined using patient-therapist ratio as a moderator (Del Re, Fl€ uckiger, Horvath, Symonds, & Wampold, 2012) . Also referred to as PTR, this variable represents the quotient of patients to therapists within a given treatment sample and can be used to index the degree to which withingroup variability may affect measured variables. When PTR is very large, for example, with all patients seeing the same therapist, therapist variability is nonexistent and does therefore not affect alliance or outcome. In such a scenario, variance in the alliance-outcome relationship should primarily be influenced by variability in patient characteristics. This changes, however, as PTR values decrease.
Hypothesis
If differences between therapists have an impact on the link between alliance and outcome, shifts in therapist variability should influence the strength of the alliance-outcome relationship. Accordingly, we should expect patient-therapist ratio to moderate effect sizes in the present meta-analysis. This would be in line with findings reported by Del Re et al. (2012) .
Method
Review registration
This meta-analysis was conducted in accordance with AMSTAR criteria for systematic reviews (Shea et al., 2007) . The corresponding protocol was preregistered on PROSPERO in June 2015 and can be found under registration number 42015023275. Use of preregistration is strongly recommended in PRISMA guidelines and marks an advance on previous meta-analyses in the alliance field (Liberati et al., 2009) . As with clinical trials, it is a widely accepted mark of quality and minimises the risk of methodological decisions being unduly influenced by findings (Quintana, 2015) .
Literature search
This meta-analysis synthesised data on the alliance-outcome relationship in adolescent study cohorts. To identify relevant literature, the following search methods were deployed: (a) Database searches of articles published before June 2015 were conducted using PsycINFO, PsycARTICLES, EMBASE, Medline, CINAHL, ERIC, PubPsych, PsyJournals and The Cochrane Library. Unpublished literature was searched for using EThOS, OpenGrey and Dissertation Abstracts International.
To restrict the search to studies with predominantly adolescent samples, the terms alliance, therapeutic relationship and bond were crossed with youth, adolescent, child and family. (b) Reviews of alliance-related topics were screened to identify reference trails.
Study titles and abstracts were screened for eligibility according to below selection criteria. Duplicates and clearly irrelevant papers were removed. The remaining studies were then examined by full text and a decision on final eligibility was made. Corresponding authors were contacted to resolve uncertainty over eligibility and were asked to provide additional information for effect size computations where required.
Selection criteria
While the present meta-analysis aimed to provide an updated effect size estimate of the alliance-outcome relationship, it was not designed to replicate prior publications. To attain a reasonable degree of comparability, however, selection criteria were modelled on those described in McLeod (2011) and read as follows: (a) the study needed to be clinical; (b) the study sample needed to comprise at least five participants; (c) interventions administered to participants needed to be psychological and target mental health difficulties; (d) studies involving participants with medical diagnoses or neurodevelopmental conditions were excluded; (e) studies involving participants with significantly impaired cognitive functioning were excluded; (f) the mean age of each study sample needed to fall within the 12-19 age range; these restrictions differ from criteria presented in previous meta-analyses to exclude samples primarily comprised of children; (g) the study needed to use formal measures of alliance and outcome; (h) outcome measures used in the study needed to assess symptom severity, global functioning, or emotional distress; (i) alliance needed to be assessed via self-report; (j) the relationship between alliance and outcome needed to be quantifiable, that is, correlation coefficients had to be obtainable; (k) the study needed to be written in English or German; these language criteria differ from previous meta-analyses to facilitate a more comprehensive screening of literature.
Data extraction
Strategy. Data extraction was carried out using predefined templates. Due to resource limitations, this process was managed by a single reviewer. Since this deviates from existing AMSTAR guidelines, it may be associated with some methodological concerns, for example, risk of error and bias (Shea et al., 2007) . We therefore advise readers to exercise caution when interpreting our findings. To increase the robustness of our extraction procedure, however, all data were doubleextracted and checked for errors. Where there was ambiguity with regard to selection decisions, discussions were held between both researchers. Patient-therapist ratio. Patient-therapist ratio was computed by dividing participant N by therapist N. Due to participant attrition, some sample sizes decreased throughout the course of administered treatment. To compute an adequately representative PTR value, the following criteria were established: (a) If sample size decreased throughout the first half of treatment, postattrition participant numbers were used to calculate PTR; (b) For studies where information on attrition was not reported, intention-to-treat participant numbers were used to calculate PTR.
Treatment variables. The impact of individual differences between therapists may differ depending on the nature of provided interventions. Psychological treatment characterised by a more structured session delivery, for instance, can be expected to decrease variation among those who administer it. It was therefore important to determine whether PTR moderates the strength of the alliance-outcome relationship when variables pertaining to treatment structure are controlled for. To assess this, two categorical variables were extracted for subsequent analysis: (a) CBT Elements (yes, no); (b) Manual Use (yes, no). 
Data analysis
Quality appraisal. Assessment of study-level bias was conducted using the Quality Assessment Tool for Quantitative Studies (Effective Public Health Practice Project, 1998). Details of quality appraisal ratings were used to interpret study findings and are presented in Table 3 .
Publication bias. Presence of publication bias was initially assessed via examination of a funnel plot. Plot asymmetry was then determined statistically using the Egger test (Egger, Smith, Schneider, & Minder, 1997) .
Effect size extraction & computation. Effect sizes for alliance-outcome relationships were extracted as Pearson's r. Where correlation coefficients were not reported, techniques described by Rosenthal (1994) were used to compute r values from alternative information. As observed in clinical practice, outcome is typically assessed against treatment goals established in collaboration with each patient. As seen in routinely used screening tools such as CORE, these typically fall within three broad domains (Evans et al., 2002) . To reflect this in the selection of effect sizes, the following conceptual hierarchy was established to guide the extraction of correlational data: (a) Symptom Severity, (b) Global Functioning, and (c) Emotional Distress. Hierarchical approaches to outcome selection have been used in several recent meta-analyses of psychiatric treatments and are preferable to computing an aggregate effect size for each study, that is, an average of all reported outcomes (e.g. Hutton & Taylor, 2014; Leucht et al., 2013; Stovell, Morrison, Panayiotou, & Hutton, 2016) . As highlighted in recent publications, it allows inclusion of a larger number of eligible studies and yields a much more interpretable effect size estimate. It also reduces the risk of meta-analytic findings being influenced by decisions made by original authors, especially in relation to the number and type of outcomes they decided to measure, or indeed the number and type of outcomes they decided to report.
Where studies used multiple measures to assess allianceoutcome correlations within the same outcome domain, the following a priori criteria were used to determine effect size selection: (a) Where multiple measures assessed the same construct, the most frequently used measure was prioritised; (b) Where different rater versions of the same outcome measure were available, participant self-report was prioritised; (c) Where outcome was measured at multiple time points, endof-treatment assessment was prioritised; where clinical outcome was only measured at posttreatment follow-up, the first follow-up assessment was prioritised; (d) Where alliance was measured at multiple time points, early-treatment alliance ratings were prioritised.
The meta-analytic estimate of the alliance-outcome relationship, that is, the mean weighted effect size across included studies, was computed using a random effects model (Raudenbush, 1994) . Keeping in line with the methodology used by Del Re et al. (2012), a restricted maximum-likelihood estimator was used to approximate the model. Effect sizes contributing to this cross-domain average were selected using the hierarchy described above. Applying the same model, pooled domain-specific effect size estimates were also computed. All analyses were performed using the 'metafor' package for metaanalyses in R (Viechtbauer, 2010). To adjust for bias in the r distribution, extracted coefficients were converted into Fisher's Z prior to analysis (Hedges & Olkin, 1985) .
Heterogeneity. The I 2 statistic was computed to index the proportion of effect size variability attributable to betweenstudy heterogeneity. Since methodological differences are common in the alliance field, heterogeneity was expected to be high.
Moderator analysis. Single-predictor meta-regression: To assess whether patient-therapist ratio moderates the strength of the alliance-outcome relationship, PTR was entered into a single-predictor meta-regression model as a moderator variable. This generated the following regression model:
with ES designating the effect size estimate of the allianceoutcome relationship, and v designating within-study and between-study error variance.
Multipredictor meta-regression: To assess whether PTR remains a statistically significant moderator in the presence of potential confounds, CBT Elements and Manual Use were entered into a multipredictor meta-regression model as additional moderator variables. This yielded the following regression model:
Results
Literature
Literature search produced an initial pool of 14,492 electronic records. After removal of duplicate entries, 5,784 records were screened by title and abstract. Throughout this process, a substantial number of previously unidentified duplicates were excluded. The remaining 178 studies were examined by full text, with 62 studies meeting initial eligibility criteria (Figure 1 ). For 35 of these studies, information was insufficient to compute usable effect sizes. The final literature sample comprised 27 studies and a total of 28 independent effect sizes.
Ten of these were derived from unpublished doctoral dissertations. Information on the 151 studies excluded (Table S1 ) following full-text screening is provided in Appendix S1. All included studies were completed between 1992 and 2015, with 12 published after 2010. Despite efforts to identify relevant non-English literature, only one study in the present sample was written in German (Cropp et al., 2008) . Table 1 displays sample characteristics and other relevant variables. Overall, included studies comprised a total of 2,911 participants (M = 103.96, SD = 101.89, range 20-470). The mean age reported for participant samples ranged from 13.10 to 18.40 years (M = 15.18, SD = 1.28), with a total cross-study age range of 7-25 years. For one study, sample mean age was not obtainable. On average, samples were comprised of approximately 51% female participants (M = 50.89, SD = 23.95, range 15%-100%). 21 of the 27 studies included in this sample (78%) were conducted in the USA. Substance abuse, behavioural difficulties, and mixed mental health presentations were addressed in seven studies (26%) each. Two studies focused on eating disorders (7%). PTSD, OCD, anxiety and mood disorders were addressed in one study (4%) each.
Sample characteristics
Patient-therapist ratio
Extracted PTR values ranged from 0.96 to 102 (M = 14.62, SD = 22.26) and displayed considerable variability across study samples. For seven studies, PTR values could not be computed and were not available from the authors.
Treatment variables
The treatment approaches used in 19 study samples (68%) drew on treatment elements akin to CBT. Treatment approaches used in the remaining samples were mainly categorised as psychotherapeutic or counselling-based. The use of treatment manuals was confirmed for 10 study samples (36%). However, the majority of studies did not report information on this variable . Table 2 presents an overview of measure-related variables. Overall, 12 different measures of therapeutic alliance were used across included studies. The Working Alliance Inventory (Horvath & Greenberg, 1989 ) was used in 10 distinct studies (37%) and stood out as the most frequently applied tool. The Therapeutic Alliance Scale for Children/Adolescents (Shirk & Saiz, 1992) , the Therapeutic Alliance Quality Scale (Bickman et al., 2010) , and the Penn Helping Alliance Questionnaire (Luborsky, 1976) were used in three studies each and thus covered one-third of the meta-analytic sample in total (33%). The remaining eight alliance measures were used in one study respectively. In 13 studies, just less than half of the present literature sample, therapeutic alliance was assessed early in treatment (48%).
Measure variables
Overall, 20 distinct measures were used to assess clinical outcome. With a total of 20 studies (74%), outcome assessment was most frequently conducted at the end of treatment, that is, the ultimate or penultimate treatment session. Four studies assessed clinical outcome at posttreatment followup (15%). Exact follow-up timing ranged from 3 to 6 months posttreatment. Early, mixed, and late outcome assessments were conducted in one study each. With a total of 20 studies (74%), symptom severity was the most commonly encountered outcome domain.
Global functioning was assessed in seven studies (26%). Outcome measures evaluating emotional distress were only used in two studies (7%). In total, two studies assessed clinical treatment outcome for multiple domains. Table 3 presents ratings on global study quality and five tool subdomains for the present literature sample. Since the subdomain covering confounding variables was only relevant to studies conducting group comparisons, it was excluded in the present quality assessment. Most studies recruited participants through referral from mental health professionals, inpatient settings, or schools and had participation rates above 60% after initial eligibility screenings. Approximately 67% of studies had moderate evidence of selection bias and recruited Trials and were thus rated as strong on study design. Where studies used secondary data analysis, the design of the original study was assessed. Most studies did not report enough information to draw definitive conclusions about the blinding of participants and outcome assessors. Following tool guidelines, these studies were rated as moderate in this subdomain. Since studies assessed therapeutic alliance through self-report questionnaires, participants were inadvertently alerted to the relevance of their patient-therapist relationship. Five studies, however, made conscious efforts to reduce possible reporting bias, for example, by assuring participants that completed questionnaires would not be viewed by therapists, or by designating questionnaire collection to another researcher. For a number of studies, it was difficult to establish whether participating therapists were aware of the research questions and the participant status of their patients. Overall, however, it appeared that therapists had knowledge of administered measures.
Quality assessment
Publication bias
Visual examination of the funnel plot displayed in Figure 2 indicated that extracted effect sizes were not symmetrically distributed, with several data points located outside the right-hand side of the funnel shape. The Egger test supported this impression and revealed significant plot asymmetry (z = 2.1058, p = .04). Assuming that plot asymmetry arose from the presence of publication bias, the trim and fill method (Duval & Tweedie, 2000) was used as a statistical correction procedure. As displayed in Figure 3 , the corresponding analysis estimated two missing studies on the left-hand side of the funnel plot and added these for subsequent analysis. Studies marked a used one participant sample only and did not make group comparisons; studies marked b took measures to reduce reporting bias; in the subdomain marked c ratings focused on the validity and reliability of measures used to quantify the allianceoutcome relationship and do therefore not represent assessments of all data collection measures; studies marked na conducted secondary data analysis, quality ratings of participant withdrawals and dropouts were thus not applicable. Studies marked with an asterisk (*) are unpublished doctoral dissertations. 
Effect size computation
Across the identified sample, all extracted correlations indicated a positive relationship between quality of patient-therapist alliance and quality of clinical outcome. This is in line with findings reported in previous meta-analyses (McLeod, 2011; Shirk & Karver, 2003; Shirk et al., 2011) . Extracted allianceoutcome correlations ranged from r = .03 to r = .71. Figure 4 presents a forest plot of all extracted effect sizes and filled studies. The mean weighted effect size of the alliance-outcome relationship, computed drawing on 28 extracted correlations, was r = .29 (95% CI: 0.21, 0.37; p < .0001). Based on the guidelines established by Cohen (1988) , this effect size was interpreted as small to moderate in magnitude. As expected, heterogeneity among effect sizes was significant (Q = 135.11, p < .0001, I 2 = 80.43%), with approximately 80% of effect size variability being attributable to between-study differences. Overall, these results indicate that differences in alliance were associated with approximately 8% of the outcome variance across included studies.
Applying the same meta-analytic model, domainspecific effect size estimates were computed in a separate analysis. The mean weighted effect size for studies assessing symptom severity, computed drawing on 21 pooled correlations, was r = .29 Figure 4 Forest plot depicting effect sizes in Fisher's Z with corresponding 95% CI Figure 3 Funnel plot containing two additional effect sizes on the left-hand side (95% CI: 0.20, 0.38; p < .0001). As described above, this estimate was also small to moderate in magnitude. Again, heterogeneity among effect sizes was high (Q = 109.24, p < .0001, I 2 = 82.87%), with approximately 83% of effect size variability being attributable to between-study differences. According to pooled data from eight independent samples, the mean weighted effect size for studies assessing global functioning was r = .33 (95% CI: 0.23, 0.42; p < .0001). Effect size heterogeneity within this outcome domain was not significant (Q = 9.70, p = .21, I 2 = 32.41%). Since only two extracted correlations assessed emotional distress, computation of a domain-specific effect size estimate did not yield statistically significant results (r = .40, 95% CI: À0.19, 0.77; p = .18).
Sensitivity analyses. Age range: The mean age of study samples needed to fall within the 12-19 range for this meta-analysis. These restrictions were established to exclude samples primarily comprised of nonadolescent participants. While all reported age means were in line with these specifications, only 56% of extracted effect sizes had participant samples with age ranges falling within the 12-19 0 bracket. To examine whether this had an impact on obtained meta-analytic results, relevant effect sizes were removed for analysis. The resulting pooled effect size estimate of the alliance-outcome relationship was still small to moderate, but somewhat larger in magnitude (r = .34; 95% CI: 0.23, 0.45; p < .0001). Heterogeneity remained high (Q = 82.93, p < .0001, I 2 = 83.11%).
Common source bias: The inclusion of study-level measures derived from self-report can inflate the magnitude of effect sizes through common source bias, particularly when estimates are computed as correlation coefficients. If present effect size estimates were affected by such inflation, excluding studies with outcomes derived from self-report should yield an average effect size that is markedly smaller than overall correlations (r = .29 to r = .34). The results of a post hoc sensitivity analysis did not support this hypothesis, however, revealing an effect size estimate very much in line with original findings (r = .33, 95% CI 0.20, 0.46; p < .0001, I 2 = 76%). 
Meta-regression
The presence of significant heterogeneity indicates that study-level variables might moderate the magnitude of effect sizes across included studies. However, PTR was not found to be a significant moderator of effect sizes within a single-predictor meta-regression analysis (b = À.0022, 95% CI: À0.01, 0.00; p = .26). Consequently, effect size heterogeneity remained high within this model (Q = 84.51, p < .0001, I 2 = 74.12%). When CBT Elements and Manual Use were controlled for in a multipredictor meta-regression analysis, these findings did not change (b = À.0029, 95% CI: À0.01, 0.00; p = .22). CBT Elements (b = .1498, 95% CI: À0.06, 0.36; p = .16) and Manual Use (b = À.1291, 95% CI: À0.38, 0.12; p = .31) were not identified as significant moderators either (Q = 75.60, p < .0001, I 2 = 73.50%).
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Discussion
Moderator analysis
Contrary to expectations, patient-therapist ratio was not identified as a significant moderator in this meta-analysis, even after treatment-level confounds were controlled for. The absence of a moderating effect does not only deviate from findings reported by Del Re et al. (2012) but also challenges the hypothesis that shifts in therapist variability influence the strength of the alliance-outcome relationship. More specifically, it seems to indicate that variance in the alliance-outcome relationship can be equally linked to patients and therapists. Interestingly, R 2 values obtained in both meta-regression analyses were below 1% and suggested that PTR did not account for any of the variability observed in synthesised effect sizes. This was also reflected by the substantial effect size heterogeneity (I 2 > 70%) remaining in both meta-regression models. Overall, these findings suggest that other, not presently assessed, factors might account for the significant variability observed across alliance-outcome correlations.
Effect size
Despite deploying more stringent selection criteria than previous publications, the present meta-analysis identified the largest pool of alliance-outcome correlations derived from predominantly adolescent samples. The average effect size was equivalent to 0.29 and thus noticeably larger than the estimate of the most recent similarly sized meta-analysis (r = .10; McLeod, 2011) . When study samples breaching the 12-19 age range were removed in a sensitivity analysis, the effect size even rose to 0.34. As these findings indicate, the strength of the adolescent allianceoutcome relationship is markedly stronger than previously assumed and can be compared to estimates reported for adult mental health patients (r = .28; Horvath et al., 2011) . More specifically, these findings also suggest that alliance may account for an unprecedented 8%-12% of variability in treatment outcomes for adolescent patients. This does not only challenge conclusions drawn in previous reviews of youth alliance, but also refocuses attention on the importance of relationship variables in psychological treatment.
Strengths & limitations
While a number of methodological differences distinguish the present meta-analysis from recent predecessors, effect size extraction is perhaps the most significant point of deviation. Since many primary studies report multiple alliance-outcome correlations for the same treatment group, reviewers are tasked with distilling this information and extracting one effect size for analysis. Previous meta-analyses have attempted to aggregate relevant data and averaged all reported correlations to obtain a mean (e.g. Shirk et al., 2011) . Unfortunately, estimates derived through aggregation are at high risk of being adversely influenced by decisions made in the original studies and often incorporate measures of unclear clinical relevance, for example, attendance rates (McLeod, 2011) . Perhaps most importantly, however, estimates based on an aggregate of multiple outcomes are also difficult for practitioners to interpret and may not provide clinically meaningful information. This makes drawing informative conclusions with regard to clinical practice very challenging. To avoid such pitfalls, the present metaanalysis used a predetermined hierarchy-based approach and extracted single unaveraged correlations for three relevant outcome domains. While this may have introduced significant heterogeneity (I 2 ≥ 70%) across effect sizes, it also provided transparent information on the clinical relevance of extracted correlations and hopefully facilitated more meaningful conclusions about the alliance-outcome relationship.
Despite other efforts to conduct a methodologically robust meta-analysis, a number of noteworthy shortcomings still exist. The extraction of study-level PTR values, for instance, was more problematic than originally anticipated and resulted in missing values for seven included studies. In all cases, this was due to unavailable information on therapist numbers and could not be resolved through initiated correspondence. To avoid reductions in PTR sample size, missing values were initially replaced by the PTR mean at analysis stage. When mean substitution is used to address missing data, researchers act on the assumption that the variable mean is sufficiently representative of missing observations. As Pigott (1994) highlighted, however, this can result in an artificial deflation of variability in the affected variable and skew further statistical analysis. When applied to a moderator, mean substitution can thus affect observed variance and artefactually mask significant moderator effects. To assess this in our present findings, both meta-regression models were repeated using complete case analysis, that is, pairwise removal of missing values. Since obtained results did not change upon reanalysis, both 'missing data' approaches seemed to be interchangeable in this instance. Nevertheless, these findings do not confirm optimal suitability of either strategy. While the present meta-analysis did not assess this in further detail, alternative approaches such as regression imputation (Buck, 1960) may have been more appropriate.
Some individual studies (e.g. Ormhaug, Shirk, & Wentzel-Larsen, 2015) suggest that the strength of the alliance-outcome correlation differs across individual rater perspectives, that is, patient, therapist and observer. The meta-analysis conducted by McLeod (2011) , however, does not support this hypothesis: Follow-up contrasts of data obtained from 38 studies found no difference between these alliance rater groups in relation to the strength of the alliance-outcome correlation. Focusing on patient ratings of alliance should therefore not, by itself, be expected to skew meta-analytic findings. Nevertheless, it is important to highlight that the present findings may still not be entirely free from bias: Since adolescents were asked to rate the patient-therapist alliance, attention was inadvertently drawn to the importance of this variable and may have elicited unrepresentative alliance reports (Furnham, 1986) . As established through quality assessments, only five studies seemed to have taken additional measures to reduce the probability of such response bias. Consequently, it is not possible to rule out that primary alliance ratings potentially contributed to an inflated effect size estimate of the alliance-outcome relationship.
Practice implications
While the results of previous meta-analyses have questioned the role of therapeutic alliance in youth treatment (McLeod, 2011) , the present meta-analysis highlighted its clinical relevance for adolescent patient groups. As present effect sizes indicate, the meta-analytic estimate of the alliance-outcome relationship is markedly larger than previously reported. Accordingly, alliance has a moderate link to subsequent outcome and may be a comparatively reliable predictor of clinical progress.
Since alliance was assessed through patient selfreport across included studies, the present findings offer insights into the effect of the patient perspective and permit comparatively specific conclusions regarding the alliance-outcome relationship. This meta-analysis is thus the first to highlight a concrete link between adolescent perceptions of alliance and treatment outcomes in three distinct domains, that is, symptom severity, global functioning, and emotional distress. Applied to routine mental health practice, these findings emphasise the informational value that regular monitoring of patient-perceived alliance can carry in treatment delivery. This could be particularly beneficial when alliance is flagged up as poor, and may enable clinicians to address relational barriers to positive treatment outcomes. As highlighted in a recent RCT, assessment of patient-reported alliance can be integrated into CBT delivery within research settings and even contribute to a positive stabilisation of the patient-therapist relationship .
As the present results indicate, alliance has a significant link to treatment success and may account for approximately 8%-12% of variability in adolescent outcomes. Even though a causal relationship has not been confirmed so far, alliance is a widely cited component of psychological therapy and may be an active agent in therapeutic change (Shirk & Saiz, 1992) . Clinicians should therefore not only be aware of relational processes, but also be able to respond to variations in alliance quality appropriately. As numerous studies indicate, this is applicable to all professionals working in a therapeutic capacity and requires skills in establishing, maintaining, and repairing alliances (Horvath & Marx, 1991) . Since adolescents constitute a particularly complex patient group, this may call for specialised professional training in relational skills. Alliance-fostering training programmes, for instance, have already been trialled in adult mental health services and yielded promising findings for a diverse group of clinicians (Crits-Christoph et al., 2006) .
Despite the recommendations highlighted above, it remains unclear how regular assessment of alliance can be integrated into routine mental health practice, particularly when ratings are requested from vulnerable patient groups such as looked-after adolescents. Being asked to rate alliance may well be anxiety-provoking for young service users and have an adverse effect on other therapeutically relevant factors, for example, patient self-disclosure. There is also very little clarity regarding the type of measure most suitable for alliance assessment in relevant service settings. To date, most measures used to assess adolescent alliance are top-down adaptations of existing adult tools and echo their respective originals quite closely. Measures specifically developed for adolescent patients, for example, the Therapeutic Alliance Scale for Children/Adolescents (Shirk & Saiz, 1992) , seem to be comparatively rare.
Further research directions
The strength of the alliance-outcome relationship can vary in the presence of certain variables. In the most extreme of cases, alliance may simply be a passive treatment feature and bear no relation to clinical outcome. While the present meta-analysis questions the impact of therapist variability on the alliance-outcome association, it is clear that more primary research is necessary to assess the role of other therapist variables. The present meta-analysis also highlighted a relative lack of primary studies with predominantly adolescent participant samples. Despite comparatively stringent selection criteria with regard to mean age, almost half of included studies had participant samples breaching the 12-19 age range. The present target population was therefore not exclusively adolescent and encompassed a noteworthy number of children under the age of 12. It is therefore advisable to repeat all present analyses once a more age-homogeneous sample of studies can be identified.
Conclusion
In contrast to previous research with adult samples, patient-therapist ratio did not emerge as a significant moderator of the alliance-outcome relationship for adolescents undergoing mental health treatment. This unexpected finding challenges the hypothesis that therapist variability has an important influence on the alliance-outcome relationship. However, present effect size estimates for adolescent patients are larger than previously reported and suggest that alliance may account for 8%-12% of variability in treatment outcomes across assessed domains. Despite a number of methodological limitations, these findings indicate that alliance is a notably more reliable predictor of adolescent treatment outcomes than previously estimated.
Supporting information
Additional Supporting Information may be found in the online version of this article: Table S1 . List of 151 excluded studies with corresponding exclusion reasons. Appendix S1. Narrative Clinical Commentary.
• The alliance-outcome relationship for adolescent mental health patients is markedly larger than previously assumed, with average effect sizes presently ranging from r = .29 to r = .34.
• Alliance as perceived by adolescents accounts for 8%-12% of variability in treatment outcomes; these are specifically linked to domains of symptoms severity, global functioning, and emotional distress.
• These findings exceed estimates previously reported for adult mental health patients and highlight the prognostic value of patient-reported alliance in psychological treatment for adolescents.
• Monitoring patient perceptions of alliance can provide valuable information in routine mental health practice and enable practitioners to address early relational barriers to positive treatment outcomes.
• Patient-therapist ratio did not moderate the strength of the alliance-outcome relationship; the idea that therapist variability affects the alliance-outcome relationship can therefore not be supported.
Areas for future research
• Conduct more primary research on the alliance-outcome relationship in adolescent patient groups.
• Repeat meta-analysis on adolescent alliance-outcome link with a more age-homogeneous sample.
• Identify moderators of adolescent alliance-outcome relationship linked to treatment variables.
• Explore how regular alliance assessment can be implemented in routine mental health practice.
• Assess suitability of alliance measures for use in Child and Adolescent Mental Health Services.
Notes
1. When studies with outcomes derived from other sources were excluded in a different sensitivity analysis, the resulting effect size estimate was comparable (r = 0.31, 95% CI 0.23, 0.37; p < .0001, I 2 = 37%). 2. The use of manuals has previously been suspected to affect alliance quality. While the metaregression results are thus somewhat surprising, they are in line with findings reported by Langer, McLeod, and Weisz (2011) .
